Economic evaluation of epilepsy in Kiremba (Burundi): A case-control study

Epilepsia

Volumn 45, Issue 6, 2004, Pages 673-677

  Nsengiyumva, Georges ^a   Druet Cabanac, Michel ^a,b   Nzisabira, Léopold ^c   Preux, Pierre Marie ^a,b   Vergnenègre, Alain ^a,b  

^a Hopital du Cluzeau   (France)

^b Cluzeau Hospital   (France)

^c University Hospital of Kamenge   (Burundi)

Author keywords

Africa; Case control study; Costs; Economic analysis; Epilepsy

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AFRICA; ARTICLE; BURUNDI; CONSULTATION; CONTROLLED STUDY; COST OF ILLNESS; ECONOMIC ASPECT; EPILEPSY; FAMILY LIFE; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SOCIAL ASPECT;

ADULT; ANTICONVULSANTS; BURUNDI; CASE-CONTROL STUDIES; COST OF ILLNESS; CROSS-CULTURAL COMPARISON; DEVELOPING COUNTRIES; DRUG COSTS; EPILEPSY; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HUMANS; MALE;

EID: 3042645499     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.36303.x     Document Type: Article

References (29)

1. Begley CE, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:1230-43.
2. Pachlatko C. The relevance of health economics to epilepsy care. Epilepsia 1999;40:3-7.
3. Preux PM, Tiemagni F, Fodzo L, et al. Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia 2000;41:432-9.
4. Shorvon SD, Farmer PJ. Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects. Epilepsia 1988;29:S36-54.
5. Drummond M, Stoddart G, Torrance G. Methods for economic evaluation of health care programmes. Oxford: Oxford University Press, 1990.
6. Begley CE, Annegers JF, Lairson DR, et al. Estimating the cost of epilepsy. Epilepsia 1999;40:S8-13.
7. Halpern M, Rentz A, Murray M. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 2000;19:87-99.
8. Kotsopoulos IA, Evers SM, Ament AJ, et al. Estimating the costs of epilepsy: an international comparison of epilepsy cost studies. Epilepsia 2001;42:634-40.
9. Murray MI, Halpern MT, Leppik IE. Cost of refractory epilepsy in adults in the USA. Epilepsy Res 1996;23:139-48.
10. Swingler RJ, Davidson DL, Roberts RC, et al. The cost of epilepsy in patients attending a specialist epilepsy service. Seizure 1994;3:115-20.
11. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000;41:342-51.
12. Cockerell OC, Hart YM, Sander JW, et al. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res 1994;18:249-60.
13. Jacoby A, Buck D, Baker G, et al. Uptake and costs of care for epilepsy: findings from a U.K. regional study. Epilepsia 1998;39:776-86.
14. Gessner U, Sagmeister M, Horisberger B. The economic impact of epilepsy in Switzerland. In: Beran RG, ed. Cost of epilepsy: Proceedings of the 20th International Epilepsy Congress. Wehr/Baden: Ciba-Geigy Verlag, 1995:67-74.
15. Johnson WG. The costs of epilepsy and cost-based evaluations of anticonvulsants. Pharmacoeconomics 1997;12:446-59.
16. Silfvenius H. Economic costs of epilepsy-treatment benefits. Acta Neurol Scand 1988;117:S136-54.
17. Banks G, Regan K, Beran R. The prevalence and directs costs of epilepsy in Australia. In: Beran RG, ed. Cost of epilepsy: Proceedings of the 20th International Epilepsy Congress. Wehr/Baden: Ciba-Geigy Verlag, 1995:39-48.
18. Galdames D, Erazo S. Cost and requirement of new antiepileptic drugs in an urban hospital in Santiago, Chile. Epilepsia 2001;42(suppl 2):26.
19. Thomas SV, Sarma PS, Alexander M, et al. Economic burden of epilepsy in India. Epilepsia 2001;42:1052-60.
20. Fandino-Franky J, Silfvenius H. World-wide disparities in epilepsy care: a Latin American outlook. Epilepsia 1999;40:S48-54.
21. Chandra B. Economic aspects of epilepsy in Indonesia. In: Beran RG, ed. Cost of epilepsy: Proceedings of the 20th International Epilepsy Congress. Wehr/Baden: Ciba-Geigy Verlag; 1995:75-82.
22. Commission on Epidemiology and Prognosis of the International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993;34:592-6.
23. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, et al. Cysticercosis as a major risk factor towards epilepsy in Burundi, East Africa. Epilepsia 2003;44:950-5.
24. Chisholm D, Sekar K, Kumar KK, et al. Guidelines for economic analysis of community mental health care programs in low-income countries. In: Committee on Nervous System Disorders in Developing Countries Institute of Medicine, eds. Neurological, psychiatric, and developmental disorders. Washington, DC: National Academy Press, 2000:397-404.
25. Bernet-Bernady P, Tabo A, Druet-Cabanac M, et al. L'épilepsie et son vécu au Nord-Ouest de la République Centrafricaine. Méd Trop 1997;57:407-11.
26. Kale R. Global campaign against epilepsy: the treatment gap. Epilepsia 2002;43:31-3.
27. Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ 2001;79:344-51.
28. Meinardi H, Scott RA, Reis R, et al. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001;42:136-49.
29. Josty IC, Narayanan V, Dickson WA. Burns in patients with epilepsy: changes in epidemiology and implications for burn treatment and prevention. Epilepsia 2000;41:453-6.